Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 278.39 |
| Open | 313.39 |
| Bid | 311.16 x 200 |
| Ask | 311.48 x 100 |
| Day's range | 308.72 - 322.60 |
| 52-week range | 211.71 - 329.72 |
| Volume | |
| Avg. volume | 2,926,438 |
| Market cap | 166.987B |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | 44.47 |
| EPS (TTM) | 7.00 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | 9.00 (2.89%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | 306.20 |
Yahoo FinanceAmgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Simply Wall St.Amgen First Quarter 2024 Earnings: EPS Misses Expectations
Amgen ( NASDAQ:AMGN ) First Quarter 2024 Results Key Financial Results Revenue: US$7.45b (up 22% from 1Q 2023). Net...
GuruFocus.comDecoding Amgen Inc (AMGN): A Strategic SWOT Insight
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats
© 2024 Yahoo. All rights reserved.